Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000461483 | SCV000546994 | uncertain significance | Ataxia-telangiectasia syndrome | 2023-12-29 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 1972 of the ATM protein (p.Lys1972Glu). This variant is present in population databases (no rsID available, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with ATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 407647). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000574705 | SCV000660646 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-02-27 | criteria provided, single submitter | clinical testing | The p.K1972E variant (also known as c.5914A>G), located in coding exon 38 of the ATM gene, results from an A to G substitution at nucleotide position 5914. The lysine at codon 1972 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587661 | SCV000694310 | uncertain significance | not specified | 2024-03-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000587661 | SCV002064559 | uncertain significance | not specified | 2019-06-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004568002 | SCV005056931 | uncertain significance | Familial cancer of breast | 2024-02-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000461483 | SCV002075485 | uncertain significance | Ataxia-telangiectasia syndrome | 2020-10-30 | no assertion criteria provided | clinical testing |